Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Stuart E Lind

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/724-1383

    Collapse Research 
    Collapse research activities and funding
    K08HL001063     (LIND, STUART E.)Jul 1, 1982 - Jun 30, 1987
    NIH/NHLBI
    NHLBI CLINICAL INVESTIGATOR AWARD PROGRAM
    Role: Principal Investigator

    R01HL042457     (LIND, STUART E.)Jan 1, 1990 - Dec 31, 1995
    NIH/NHLBI
    INTERACTION OF ACTIN WITH PLASMA PROTEINS AND PLATELETS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Vanderbilt CM, McFarland C, Lind SE. Evaluation of a Reflex Testing Algorithm for Suspected Heparin-Induced Thrombocytopenia. Am J Clin Pathol. 2017 Nov 02; 148(5):390-397. PMID: 29059268.
      View in: PubMed
    2. Beyer J, Trujillo T, Fisher S, Ko A, Lind SE, Kiser TH. Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors. Clin Appl Thromb Hemost. 2016 Jul; 22(5):423-8. PMID: 26842561.
      View in: PubMed
    3. Wang S, Hannafon BN, Lind SE, Ding WQ. Zinc Protoporphyrin Suppresses ß-Catenin Protein Expression in Human Cancer Cells: The Potential Involvement of Lysosome-Mediated Degradation. PLoS One. 2015; 10(5):e0127413. PMID: 26000787; PMCID: PMC4441374.
    4. Lind SE, Boyle ME, Fisher S, Ishimoto J, Trujillo TC, Kiser TH. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples. Am J Clin Pathol. 2014 May; 141(5):665-74. PMID: 24713737.
      View in: PubMed
    5. Wang S, Hannafon BN, Wolf RF, Zhou J, Avery JE, Wu J, Lind SE, Ding WQ. Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation. J Nutr Biochem. 2014 May; 25(5):515-25. PMID: 24613086; PMCID: PMC3988241.
    6. Wang S, Avery JE, Hannafon BN, Lind SE, Ding WQ. Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt/ß-catenin signaling pathway. Biochem Pharmacol. 2013 Jun 01; 85(11):1611-8. PMID: 23523860.
      View in: PubMed
    7. Zhou J, Zhang S, Xue J, Avery J, Wu J, Lind SE, Ding WQ. Activation of peroxisome proliferator-activated receptor a (PPARa) suppresses hypoxia-inducible factor-1a (HIF-1a) signaling in cancer cells. J Biol Chem. 2012 Oct 12; 287(42):35161-9. PMID: 22932900; PMCID: PMC3471732.
    8. Zheng J, Payne K, Taggart JE, Jiang H, Lind SE, Ding WQ. Trolox enhances curcumin's cytotoxicity through induction of oxidative stress. Cell Physiol Biochem. 2012; 29(3-4):353-60. PMID: 22508043; PMCID: PMC3711579.
    9. Deng XS, Wang S, Deng A, Liu B, Edgerton SM, Lind SE, Wahdan-Alaswad R, Thor AD. Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle. 2012 Jan 15; 11(2):367-76. PMID: 22189713.
      View in: PubMed
    10. Liu B, Fan Z, Edgerton SM, Yang X, Lind SE, Thor AD. Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions. Cell Cycle. 2011 Sep 01; 10(17):2959-66. PMID: 21862872.
      View in: PubMed
    11. Jiang H, Taggart JE, Zhang X, Benbrook DM, Lind SE, Ding WQ. Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline). Cancer Lett. 2011 Dec 15; 312(1):11-7. PMID: 21899946; PMCID: PMC3395224.
    12. Zhang X, Yu H, Lou JR, Zheng J, Zhu H, Popescu NI, Lupu F, Lind SE, Ding WQ. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem. 2011 Jan 14; 286(2):1429-35. PMID: 21059650; PMCID: PMC3020751.
    13. Zheng J, Lou JR, Zhang XX, Benbrook DM, Hanigan MH, Lind SE, Ding WQ. N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death. Cancer Lett. 2010 Dec 08; 298(2):186-94. PMID: 20667650; PMCID: PMC3881362.
    14. Ding WQ, Lind SE. Metal ionophores - an emerging class of anticancer drugs. IUBMB Life. 2009 Nov; 61(11):1013-8. PMID: 19859983.
      View in: PubMed
    15. Lind SE, Park JS, Drexler JW. Pyrithione and 8-hydroxyquinolines transport lead across erythrocyte membranes. Transl Res. 2009 Sep; 154(3):153-9. PMID: 19665691.
      View in: PubMed
    16. Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD. Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle. 2009 Jul 01; 8(13):2031-40. PMID: 19440038.
      View in: PubMed
    17. Prodan CI, Bottomley SS, Vincent AS, Cowan LD, Greenwood-Van Meerveld B, Holland NR, Lind SE. Copper deficiency after gastric surgery: a reason for caution. Am J Med Sci. 2009 Apr; 337(4):256-8. PMID: 19365170.
      View in: PubMed
    18. Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. 2009 Mar 15; 8(6):909-15. PMID: 19221498.
      View in: PubMed
    19. Yu H, Zhou Y, Lind SE, Ding WQ. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 2009 Jan 01; 417(1):133-9. PMID: 18764784.
      View in: PubMed
    20. Ding WQ, Yu HJ, Lind SE. Zinc-binding compounds induce cancer cell death via distinct modes of action. Cancer Lett. 2008 Nov 28; 271(2):251-9. PMID: 18639975.
      View in: PubMed
    21. Ding WQ, Lind SE. Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Mol Cancer Ther. 2007 Apr; 6(4):1467-74. PMID: 17431126.
      View in: PubMed
    22. Prodan CI, Bottomley SS, Vincent AS, Cowan LD, Holland NR, Lind SE. Hypocupremia associated with prior vitamin B12 deficiency. Am J Hematol. 2007 Apr; 82(4):288-90. PMID: 16986134.
      View in: PubMed
    23. Prodan CI, Bottomley SS, Holland NR, Lind SE. Relapsing hypocupraemic myelopathy requiring high-dose oral copper replacement. J Neurol Neurosurg Psychiatry. 2006 Sep; 77(9):1092-3. PMID: 16914761; PMCID: PMC2077729.
    24. Ding WQ, Liu B, Vaught JL, Palmiter RD, Lind SE. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol Cancer Ther. 2006 Jul; 5(7):1864-72. PMID: 16891473.
      View in: PubMed
    25. Huang X, Ding WQ, Vaught JL, Wolf RF, Morrissey JH, Harrison RG, Lind SE. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood. 2006 Feb 01; 107(3):980-6. PMID: 16195337; PMCID: PMC1895899.
    26. Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE. Anticancer activity of the antibiotic clioquinol. Cancer Res. 2005 Apr 15; 65(8):3389-95. PMID: 15833873.
      View in: PubMed
    27. Ding WQ, Vaught JL, Yamauchi H, Lind SE. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. Mol Cancer Ther. 2004 Sep; 3(9):1109-17. PMID: 15367705.
      View in: PubMed
    28. Lee J, Li S, Torbenson M, Liu QZ, Lind S, Mulvihill JJ, Bane B, Wang J. Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases. Cancer Genet Cytogenet. 2004 Feb; 149(1):53-7. PMID: 15104283.
      View in: PubMed
    29. Lind SE, Caprini JA, Goldshteyn S, Dohnal JC, Vesely SK, Shevrin DH. Correlates of thrombin generation in patients with advanced prostate cancer. Thromb Haemost. 2003 Jan; 89(1):185-9. PMID: 12540969.
      View in: PubMed
    30. Barry CP, Lind SE. Adenosine-mediated killing of cultured epithelial cancer cells. Cancer Res. 2000 Apr 01; 60(7):1887-94. PMID: 10766176.
      View in: PubMed
    31. Lind SE, Goldshteyn S, Barry CP, Lindquist JR, Piergies AA, Rosen T, Schneider JR, Shevrin DH, Caprini JA. Assessment of coagulation system activation using spot urine measurements. Blood Coagul Fibrinolysis. 1999 Jul; 10(5):285-9. PMID: 10456620.
      View in: PubMed
    32. Vasconcellos CA, Lind SE. Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood. 1993 Dec 15; 82(12):3648-57. PMID: 8260702.
      View in: PubMed
    33. Lind SE, McDonagh JR, Smith CJ. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate. Blood. 1993 Sep 01; 82(5):1522-31. PMID: 8364203.
      View in: PubMed
    34. Janmey PA, Lamb JA, Ezzell RM, Hvidt S, Lind SE. Effects of actin filaments on fibrin clot structure and lysis. Blood. 1992 Aug 15; 80(4):928-36. PMID: 1323346.
      View in: PubMed
    35. Lind SE. The institutional review board: an evolving ethics committee. J Clin Ethics. 1992; 3(4):278-82. PMID: 1463879.
      View in: PubMed
    36. Lind SE. The bleeding time does not predict surgical bleeding. Blood. 1991 Jun 15; 77(12):2547-52. PMID: 2043759.
      View in: PubMed
    37. Lind SE. Finder's fees for research subjects. N Engl J Med. 1990 Jul 19; 323(3):192-5. PMID: 2362609.
      View in: PubMed
    38. Cunningham CC, Lind SE. Apparent response of refractory post-transfusion purpura to splenectomy. Am J Hematol. 1989 Feb; 30(2):112-3. PMID: 2913759.
      View in: PubMed
    39. Lind SE. Innovative medical therapies: between practice and research. Clin Res. 1988 Oct; 36(6):546-51. PMID: 3180683.
      View in: PubMed
    40. Smith DB, Janmey PA, Sherwood JA, Howard RJ, Lind SE. Decreased plasma gelsolin levels in patients with Plasmodium falciparum malaria: a consequence of hemolysis? Blood. 1988 Jul; 72(1):214-8. PMID: 2839253.
      View in: PubMed
    41. Janmey PA, Lind SE. Capacity of human serum to depolymerize actin filaments. Blood. 1987 Aug; 70(2):524-30. PMID: 3038216.
      View in: PubMed
    42. Lind SE. Dilemmas in paying for clinical research: the view from the IRB. IRB. 1987 Mar-Apr; 9(2):1-5. PMID: 11649900.
      View in: PubMed
    43. Lind SE, Weitzman SA. The insidious development of symptomatic secondary hormone syndromes in patients with malignant endocrine tumors. Am J Med Sci. 1985 Sep; 290(3):107-10. PMID: 2996349.
      View in: PubMed
    44. Shasby DM, Lind SE, Shasby SS, Goldsmith JC, Hunninghake GW. Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood. 1985 Mar; 65(3):605-14. PMID: 3838256.
      View in: PubMed
    45. Lind SE. Can patients be asked to pay for experimental treatment? Clin Res. 1984 Oct; 32(4):393-8. PMID: 6509865.
      View in: PubMed
    Lind's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)